Abbott Capital Management

Investors carefully consider the team dynamics of a private equity GP.

When considering a spinout fund, investors need more than evidence of a strong track record.

Three veterans of the private equity fundraising market share advice to GPs thinking of spinning out to form their own firms.

Daniel Feder of Washington University Investment Mangement Company and Jonathan Roth of Abbott Capital discuss whether investors should give up on investing in clean technology.

Four limited partners discuss emerging managers and whether or not they would invest in a first- time fund.

Endowments are becoming more and more like institutional investors, says Jonathan Roth of Abbott Capital.

Limited partners from Abbott Capital, Washington University Investment Management Co., Caspian Private Equity, and Allianz Capital Partners discuss the current climate in private equity.

A constant over the last 30 years in the private equity industry is the type of people who are successful as private capital investors, says Abbott Capital’s Jonathan Roth.

Three fundraising experts discuss the regulatory complications that GPs not based in the U.S. can encounter when coming to the country to raise a fund.

Three fundraising experts discuss how to get noticed when you first come to the U.S. to fundraise.

Three fundraising experts give an introduction to the vastness and importance of fundraising in the U.S. market, particularly for non-U.S. GPs seeking to grow.

A summary of the Privcap thought-leadership series on the Top Tips for Private Equity Spinouts.

In this report, Privcap, in partnership with Preqin, presents the views of several influential limited partners on the subject of investing in first-time funds.

Three experts discuss what non-U.S. GPs need to know before coming to the U.S. to fundraise.